| Literature DB >> 26500682 |
Bahareh Khosravi1, Saeedeh Pourahmad2, Amin Bahreini3, Saman Nikeghbalian4, Goli Mehrdad5.
Abstract
BACKGROUND: Transplantation is the only treatment for patients with liver failure. Since the therapy imposes high expenses to the patients and community, identification of effective factors on survival of such patients after transplantation is valuable.Entities:
Keywords: Cox Proportional Hazards Model; Liver Transplantation; Neural Network
Year: 2015 PMID: 26500682 PMCID: PMC4612564 DOI: 10.5812/hepatmon.25164
Source DB: PubMed Journal: Hepat Mon ISSN: 1735-143X Impact factor: 0.660
Description of Qualitative Input Features for All Patients in the Study [a]
| Variable Name | No. (%) |
|---|---|
|
| |
| Male | 734 (62.80) |
| Female | 434 (37.20) |
|
| |
| Metabolic | 180 (15.40) |
| Cholestatic | 233 (19.90) |
| Hepatitis | 455 (39.00) |
| Tumors | 16 (1.40) |
| Cryptogenic | 71 (6.10) |
| Other causes | 213 (18.2) |
|
| |
| No | 1011 (86.6) |
| Yes | 157 (13.4) |
|
| |
| < 20 | 619 (53.00) |
| > 20 | 549 (47.00) |
|
| |
| A | 130 (11.1) |
| B | 506 (43.3) |
| C | 532 (45.5) |
|
| |
| No | 1022 (87.5) |
| Yes | 146 (12.5) |
|
| |
| No | 1119 (95.8) |
| Yes | 49 (4.2) |
|
| |
| Whole organ | 980 (83.9) |
| Split | 63 (5.4) |
| Living | 125 (10.7) |
|
| |
| No | 1156 (99.00) |
| Yes | 12 (1.00) |
|
| |
| No | 1099 (94.10) |
| Yes | 69 (5.90) |
|
| |
| No | 918 (78.60) |
| Yes | 250 (21.4) |
|
| |
| No | 1104 (94.50) |
| Yes | 64 (5.50) |
|
| |
| No | 1065 (91.20) |
| Yes | 103 (8.80) |
|
| |
| No | 1127 (96.50) |
| Yes | 41 (3.50) |
|
| |
| No | 1099 (94.10) |
| Yes | 69 (5.90) |
|
| |
| No | 958 (82.00) |
| Yes | 210 (18.00) |
|
| |
| No | 693 (59.30) |
| Yes | 475 (40.70) |
|
| |
| No | 1132 (96.9) |
| Yes | 36 (3.10) |
|
| |
| No | 1140 (97.6) |
| Yes | 28 (2.40) |
|
| |
| No | 1151 (98.50) |
| Yes | 17 (1.5) |
|
| |
| Male | 786 (67.30) |
| Female | 382 (32.70) |
|
| |
| Living | 127 (10.90) |
| Trauma | 651 (55.70) |
| CVA | 292 (25.00) |
| Other | 98 (8.40) |
aAbbreviations: CMV: Cytomegalovirus; CHILD Score/Class: Child-Turcotte-Pugh Score/Class; MELD: Model for End Stage Liver Disease; PELD: Pediatric End Stage Liver Disease; PTLD: Post-transplant lymphoproliferative disorder.
bDiabetes, heart failure and Lung disease.
cHepatic Artery Thrombosis, Portal Vein Thrombosis, Hepatic Artery Stenosis.
dlung infection like Pneumonia.
eDiagnosis of recurrence of the disease.
Description of Quantitative Input features for All Patients in the Study
| Variable Name | Values [ |
|---|---|
|
| 32.39 ± 17.59 |
|
| 59.12 ± 22.30 |
|
| 9.16 ± 2.20 |
|
| 162.27 ± 222.61 |
|
| 0.86 ± 0.58 |
|
| 2.03 ± 1.28 |
|
| 8.27 ± 10.27 |
|
| 6.69 ± 3.50 |
|
| 0.81 ± 0.22 |
|
| 2.40 ± 2.89 |
|
| 3.10 ± 3.97 |
|
| 1700 ± 1679.38 |
|
| 6.01 ± 1.27 |
|
| 13.81 ± 7.86 |
|
| 30.76 ± 14.19 |
a values are presented as Mean ± SD.
b International Normalized Ratio.
One to Five Years Survival Probabilities of the Patients With Transplant
| Follow Up Period, yr | Total Data (n = 1168) [ |
|---|---|
|
| 0.909 ± 0.009 |
|
| 0.888 ± 0.010 |
|
| 0.854 ± 0.014 |
|
| 0.843 ± 0.016 |
|
| 0.833 ± 0.018 |
a Values are presented as Prob. ± SE.
Comparison Criteria for Both Models on Testing Set [a]
| Comparison Criteria | Artificial Neural Network | Cox Proportional Hazards |
|---|---|---|
|
| 0.864 (0.043) [ | 0.806 (0.067) [ |
|
| 0.588 | 0.576 |
|
| 78.3 | 65.2 |
|
| 80.6 | 92.4 |
|
| 30.5 | 48.4 |
|
| 97.1 | 96.1 |
|
| ||
| Survival | 170 (97.1) | 195 (96.1) |
| Dead | 41 (69.5) | 16 (51.6) |
| Total | 211 (90.2) | 211 (90.2) |
a Cut points based on Youden associated criterion: ANN = 0.177 and Cox PH = 0.184.
b Level of significance = 0.01.
c values unit is %.
d Values are presented as No. (%).
The Order of Important Variables Based on Cox Proportionsl Hazardregression [a]
| Variables | Cox Regression Model | ||
|---|---|---|---|
| Beta | SE | P Value | |
|
| < 0.001 | ||
| Whole organ | -3.563 | 1.141 | 0.002 |
| Split | -2.112 | 1.095 | 0.054 |
| Living | |||
|
| 2.911 | 0.439 | < 0.001 |
|
| 1.822 | 0.299 | < 0.001 |
|
| 1.602 | 0.232 | < 0.001 |
|
| 1.599 | 0.239 | < 0.001 |
|
| 0.903 | 0.222 | < 0.001 |
|
| -0.646 | 0.204 | 0.002 |
|
| -0.797 | 0.283 | 0.005 |
|
| -0.033 | 0.012 | 0.006 |
|
| 0.698 | 0.283 | 0.013 |
|
| 0.698 | 0.283 | 0.013 |
|
| 0.414 | 0.197 | 0.035 |
|
| 0.036 | ||
| Trauma | 2.390 | 1.095 | 0.029 |
| CVA | 2.666 | 1.106 | 0.016 |
| Other | 2.726 | 1.166 | 0.019 |
| Living | |||
|
| 0.019 | 0.009 | 0.046 |
|
| 0.015 | 0.008 | 0.053 |
|
| -0.012 | 0.008 | 0.101 |
a Abbreviations: PC: Pack cell; PNF: Primary non function.
b P value < 0.05.
c P value < 0.10.
The Order of Important Variables Based on ANN Models [a]
| Variables | ANN Model |
|---|---|
| Mean Weights | |
|
| -0.214 |
|
| -0.171 |
|
| 0.154 |
|
| 0.152 |
|
| 0.144 |
|
| -0.133 |
|
| -0.122 |
|
| 0.112 |
|
| 0.107 |
|
| -0.105 |
|
| 0.103 |
|
| -0.103 |
|
| 0.096 |
|
| -0.095 |
|
| -0.094 |
|
| -0.093 |
a Abbreviations: CIT: Cold ischemia time; FFP: Fresh frozen plasma; PC: Pack cell; PNF: Primary non function.